<!DOCTYPE html>
<html>
<body>
<center>
<h2 align="left" style="color:red">TO GO BACK TO THE PREVIOUS PAGE CLICK ON THE IMAGE BELOW:</h2>
<a href="https://sahelili.github.io/filetwolink/" title="click here"><img src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcQY51ChA3WeA4heJyw6z0obcwtbFy93tleEwA&usqp=CAU" border="5" style="color:black" width="70" height="60">
</a>


<h1 style="color:darkred;"><u>INFORMATION ON COVID-19 VACCINE</h1></u>
<h2><u>UNORDERED LIST</h2></u>
<img align="right" src="data:image/jpeg;base64,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" width="500"height="400">
<p align="left"style="color:darkblack;"><font size="+3">What COVID-19 vaccines have been authorized and how do they work?</p></font size>
<p align="left"style="color:navy;"><font size="+2">Currently, several COVID-19 vaccines are in clinical trials. The FDA will review the results of these trials before approving COVID-19 vaccines for use. But because there is an urgent need for COVID-19 vaccines and the FDA's vaccine approval process can take months to years, the FDA will first be giving emergency use authorization to COVID-19 vaccines based on less data than is normally required. The data must show that the vaccines are safe and effective before the FDA can give emergency use authorization. Vaccines with FDA emergency use authorization include:</p></font>
<ul align="left"style="list-style-type:square">
<font size="+2">
<li style="color:navy;"><span style="color:brown"><font size="+3">Pfizer-BioNTech COVID-19 vaccine:</span></font> The Pfizer-BioNTech COVID-19 vaccine is 95% effective in preventing the COVID-19 virus with symptoms in people age 16 and older. The vaccine is 100% effective in preventing the COVID-19 virus in children ages 12 through 15. This vaccine is for people age 12 and older. It requires two injections given 21 days apart. The second dose can be given up to six weeks after the first dose, if needed.</li>
<li style="color:navy;"><span style="color:brown"><font size="+3">Moderna COVID-19 vaccine:</span></font> The Moderna COVID-19 vaccine is 94% effective in preventing the COVID-19 virus with symptoms. This vaccine is for people age 18 and older. It requires two injections given 28 days apart. The second dose can be given up to six weeks after the first dose, if needed.</li>
<li style="color:navy;"><span style="color:brown"><font size="+3">Janssen/Johnson & Johnson COVID-19 vaccine:</span></font> In clinical trials, this vaccine was 66% effective in preventing the COVID-19 virus with symptoms — as of 14 days after vaccination. The vaccine also was 85% effective at preventing severe disease with the COVID-19 virus — at least 28 days after vaccination. This vaccine is for people age 18 and older. It requires one injection. The FDA and the Centers for Disease Control and Prevention (CDC) have recommended that use of this vaccine continue in the U.S. because the benefits outweigh the risks. If you are given this vaccine, you should be educated about the possible risks and symptoms of a blood clotting problem.</li>
</ul>
</font>
<h2><u>ORDERED LIST</h2></u>
<img align="right" src="https://encrypted-tbn0.gstatic.com/images?q=tbn:ANd9GcS_Yek5wSaetukCmS2fPz6Nz3M5HxiC2y226A&usqp=CAU" width="500" height="400">
<p align="left"style="color:darkblack;"><font size="+3">What COVID-19 vaccines have been authorized and how do they work?</p></font size>
<p align="left"style="color:navy;"><font size="+2">Currently, several COVID-19 vaccines are in clinical trials. The FDA will review the results of these trials before approving COVID-19 vaccines for use. But because there is an urgent need for COVID-19 vaccines and the FDA's vaccine approval process can take months to years, the FDA will first be giving emergency use authorization to COVID-19 vaccines based on less data than is normally required. The data must show that the vaccines are safe and effective before the FDA can give emergency use authorization. Vaccines with FDA emergency use authorization include:</p></font>
<ol align="left">
<font size="+2">
<li style="color:navy;"><span style="color:brown"><font size="+3">Pfizer-BioNTech COVID-19 vaccine:</span></font> The Pfizer-BioNTech COVID-19 vaccine is 95% effective in preventing the COVID-19 virus with symptoms in people age 16 and older. The vaccine is 100% effective in preventing the COVID-19 virus in children ages 12 through 15. This vaccine is for people age 12 and older. It requires two injections given 21 days apart. The second dose can be given up to six weeks after the first dose, if needed.</li>
<li style="color:navy;"><span style="color:brown"><font size="+3">Moderna COVID-19 vaccine:</span></font> The Moderna COVID-19 vaccine is 94% effective in preventing the COVID-19 virus with symptoms. This vaccine is for people age 18 and older. It requires two injections given 28 days apart. The second dose can be given up to six weeks after the first dose, if needed.</li>
<li style="color:navy;"><span style="color:brown"><font size="+3">Janssen/Johnson & Johnson COVID-19 vaccine:</span></font> In clinical trials, this vaccine was 66% effective in preventing the COVID-19 virus with symptoms — as of 14 days after vaccination. The vaccine also was 85% effective at preventing severe disease with the COVID-19 virus — at least 28 days after vaccination. This vaccine is for people age 18 and older. It requires one injection. The FDA and the Centers for Disease Control and Prevention (CDC) have recommended that use of this vaccine continue in the U.S. because the benefits outweigh the risks. If you are given this vaccine, you should be educated about the possible risks and symptoms of a blood clotting problem.</li>
</ol>
</font>
</body>
</html>
